关注
Farid Ahmad Siddiqui
Farid Ahmad Siddiqui
Turku Bioscience Centre, University of Turku and Abo Akademi Univerisity
在 utu.fi 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition
FA Siddiqui, G Prakasam, S Chattopadhyay, AU Rehman, RA Padder, ...
Scientific reports 8 (1), 8323, 2018
1352018
Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2
MA Iqbal, FA Siddiqui, V Gupta, S Chattopadhyay, P Gopinath, B Kumar, ...
Molecular cancer 12, 1-12, 2013
1062013
Silibinin induces metabolic crisis in triple‐negative breast cancer cells by modulating EGFR‐MYC‐TXNIP axis: potential therapeutic implications
MA Iqbal, S Chattopadhyay, FA Siddiqui, A Ur Rehman, S Siddiqui, ...
The FEBS journal 288 (2), 471-485, 2021
422021
PDE6D inhibitors with a new design principle selectively block K-Ras activity
FA Siddiqui, C Alam, P Rosenqvist, M Ora, A Sabt, GB Manoharan, ...
ACS omega 5 (1), 832-842, 2019
302019
Missense mutations in pyruvate kinase M2 promote cancer metabolism, oxidative endurance, anchorage independence, and tumor growth in a dominant negative manner
MA Iqbal, FA Siddiqui, N Chaman, V Gupta, B Kumar, P Gopinath, ...
Journal of Biological Chemistry 289 (12), 8098-8105, 2014
282014
Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer
MA Iqbal, S Siddiqui, A Ur Rehman, FA Siddiqui, P Singh, B Kumar, ...
Molecular oncology 15 (5), 1450-1465, 2021
262021
ERK2-pyruvate kinase axis permits phorbol 12-myristate 13-acetate-induced megakaryocyte differentiation in K562 cells
N Chaman, MA Iqbal, FA Siddiqui, P Gopinath, RNK Bamezai
Journal of Biological Chemistry 290 (39), 23803-23815, 2015
172015
A subset of flavaglines inhibits KRAS nanoclustering and activation
H Yurugi, Y Zhuang, FA Siddiqui, H Liang, S Rosigkeit, Y Zeng, ...
Journal of cell science 133 (12), jcs244111, 2020
152020
Novel small molecule Hsp90/Cdc37 interface inhibitors indirectly target K-Ras-signaling
FA Siddiqui, H Parkkola, V Vukic, C Oetken-Lindholm, A Jaiswal, ...
Cancers 13 (4), 927, 2021
142021
Medium-Throughput Detection of Hsp90/Cdc37 Protein–Protein Interaction Inhibitors Using a Split Renilla Luciferase-Based Assay
FA Siddiqui, H Parkkola, GB Manoharan, D Abankwa
SLAS DISCOVERY: Advancing the Science of Drug Discovery 25 (2), 195-206, 2020
132020
Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1
IMD Posada, B Lectez, FA Siddiqui, C Oetken-Lindholm, M Sharma, ...
Scientific Reports 7 (1), 8944, 2017
132017
NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane
IM Ahearn, F Siddiqui, D Abankwa, MR Philips
Life Science Alliance 4 (5), 2021
112021
Elaiophylin is a potent hsp90/cdc37 protein interface inhibitor with k-ras nanocluster selectivity
FA Siddiqui, V Vukic, TA Salminen, D Abankwa
Biomolecules 11 (6), 836, 2021
72021
FLIM-FRET analysis of Ras nanoclustering and membrane-anchorage
H Parkkola, FA Siddiqui, C Oetken-Lindholm, D Abankwa
Ras Activity and Signaling: Methods and Protocols, 233-250, 2021
72021
Development of Novel Drugs Targeting Chaperones of Oncogenic K-Ras
FA Siddiqui
Åbo Akademi-Åbo Akademi University, 2021
2021
ERK2-PYRUVATE KINASE AXIS PERMITS PMA-INDUCED MEGAKARYOCYTE DIFFERENTIATION IN K562 CELLS
N Chaman, MA Iqbal, FA Siddiqui, P Gopinath, RNK Bamezai
2015
系统目前无法执行此操作,请稍后再试。
文章 1–16